For decades, newborns in the U.S. have been given the hepatitis B vaccine. This could change. A CDC vaccine advisory panel may vote to end that routine vaccination. Here's what parents should know.

Public health experts warn any delay to the newborn dose of the hepatitis B vaccine could threaten decades of progress.

A federal vaccine advisory committee this week is expected to discuss whether newborns should still get the hepatitis B vaccine — the first shot found to prevent cancer.

Pelosi is a scientific manager and researcher. Perkins is a senior advisor in governance. Remak is a patient advocate. Seid is a vaccine program lead. Romanowska is a fact-checking expert addressing misinformation and disinformation. Globally, infectious ...

Advisers to the Centers for Disease Control Prevention will scrutinize the childhood vaccine schedule and may start to upend it.

Health secretary Robert Kennedy has questioned the safety of the vaccine and has downplayed the risk of contracting the virus.

The federal vaccine panel appointed by Health Secretary Robert F. Kennedy Jr. is likely to decide on Thursday that the shots should be delayed for infants whose mothers test negative for the virus.

Robert F. Kennedy's hand-picked vaccine advisory board unexpectedly delayed its vote on the future hepatitis B vaccine's future

The best way to prevent hepatitis B infection is vaccination. The vaccines are highly effective at preventing infection in infants and for long-term protection into adulthood.